Community/Retail

Joe Moose, PharmD, details the hurdles he has come across in today's pharmacy landscape.

Janssen Research & Development, LLC today announced a collaboration with the International Union Against Tuberculosis and Lung Disease to include SIRTURO® in the STREAM study. The STREAM study is an ongoing, multi-center international randomized controlled trial to evaluate a standardized treatment regimen of anti-tuberculosis drugs for patients with multidrug-resistant tuberculosis.

COL William Pickard, RPh, MS, discusses how his area of practice has changed since he received a 2013 Next-Generation Pharmacistâ„¢ award.

As the 2012 Next-Generation Pharmacist, Joe Moose, PharmD, offers advice to the 2014 Next-Generation Pharmacistâ„¢ award winners and finalists.

COL William Pickard, RPh, MS, describes the impact that the 2013 Lifetime Achievement award has had on his career.

Joe Moose, PharmD, offers his thoughts on the 2014 Next-Generation Pharmacistâ„¢ award finalists.

Chirag Patel, PharmD, a Walgreens pharmacist in Union, New Jersey, discusses how pharmacists can extend the celebration of American Pharmacists Month beyond October.

Joe Moose, PharmD, describes how the Next-Generation Pharmacistâ„¢ award nominations have changed over the years.

The World Health Organization is criticizing the drug industry for delaying the development of an Ebola vaccine.

According to data presented at ObesityWeek 2014, 9 of 10 obese participants in the phase 3 SCALE Obesity and Prediabetes study lost weight with Novo Nordisk's liraglutide treatment alongside diet and exercise, compared with 65% receiving placebo.

For the first time since the practice of emergency medicine pharmacy was established, the services and value of pharmacists in the emergency department are officially being recognized.

The FDA today approved a drug previously granted Orphan Drug Designation for the treatment of gastric cancer after prior chemotherapy.

The vast majority of the 116 US Representatives who cosponsored legislation supporting provider status for pharmacists were reelected to Congress yesterday, according to a Pharmacy Times analysis of midterm election results.

Allergy & Asthma Network today announced a unique collaboration at the ACAAI's 2014 Annual Scientific Meeting in Atlanta. Both membership organizations will combine their specialized expertise and skills to help patients manage chronic conditions while updating health care professionals, pharmacies, and government officials about current best practices.

The Sheriff's Office in San Mateo County, California, is searching for a man suspected of robbing at least 6 pharmacies in San Francisco at gunpoint while allegedly dressed up as a clown.

An experimental ovarian cancer treatment failed to demonstrate statistically significant improvements in overall survival during a phase 3 trial.

North Dakota voters rejected a measure on yesterday's ballot to abolish a law that requires a licensed pharmacist to hold majority ownership of any pharmacy in the state.

With concerns of a potential Ebola outbreak in the United States still heightened, a pharmaceutical disaster response group is readying pharmacists with a series of resources on the virus.

Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, today announced the launch of Paricalcitol Injection, a generic version of AbbVie's Zemplar®. Hospira obtained U.S. Food and Drug Administration (FDA) approval of paricalcitol on Oct. 21 and launched the product Nov. 1.

Allergan, Inc. today commented on the ruling in the United States District Court for the Central District of California in the Company's federal securities litigation against Valeant Pharmaceuticals International, Inc., Pershing Square Capital Management, L.P. and its principal, William A. Ackman.

The new Diabetes Health Coach creates a personalized experience designed to help people living with diabetes improve their diabetes management.

Actavis plc, a leading global specialty pharmaceutical company, today announced that Chief Financial Officer R. Todd Joyce will retire from Actavis in early 2015. To ensure a smooth transition, the Company said Mr. Joyce will continue as the Company's CFO until a successor is named. Actavis has engaged a leading executive search firm to identify a successor.

The first buccal film formulation of buprenorphine and naloxone is anticipated to reach retail pharmacies by the end of this week, offering a new treatment option to the more than 2.5 million opioid-dependent patients in the United States.

The National Community Pharmacists Association applauds the Department of Labor ERISA Advisory Council for voting unanimously yesterday to recommend that DOL extend existing financial disclosure requirements to pharmacy benefit managers.